TGF-β promotes the EMT process by inducing transcription factors that suppress epithelial markers and enhance the expression of mesenchymal phenotypes, suggesting that TGF-β is a central mediator of the metastatic potential of cancer cells [36]. This evidence concerns the gene TGFB1 and cancer.